Literature DB >> 8972026

Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells.

M Jardí1, J Inglés-Esteve, M Burgal, C Azqueta, F Velasco, C López-Pedrera, L A Miles, J Félez.   

Abstract

The urinary type plasminogen activator, urokinase (uPA) is localized on the cell surface through the binding of a specific receptor, the uPA receptor (uPAR). The uPA localization enhances plasmin formation on the cell surface and facilitates cell migration. The cellular and tissue distribution of uPAR is not fully established. We have analyzed uPAR expression in nine leukemic cell lines of distinct lineages and maturational states and correlated this with expression of plasminogen receptors, tissue-type plasminogen activator (tPA) receptors and LDL receptor-related protein (LRP). The most immature and least differentiated cell line (an erythro-myeloid cell line) and cells of lymphoid lineage, did not express uPAR, whereas cells differentiated along the myelo-monocytic pathway displayed this receptor. Plasminogen and tPA receptors were expressed by all leukemic cell lines and by all nucleated peripheral blood cells but B and T lymphocytes were negative for cell surface expression of both uPAR and LRP while monocytes and neutrophils were positive for expression of both uPAR and LRP. PMA stimulation induced surface expression of uPAR in lymphocytes but did not induce expression of LRP by these cells. In contrast, lymphoid cell lines were negative for uPAR expression even after PMA stimulation, indicating differences in regulation of uPAR expression between lymphocytes and lymphoid cell lines. The pattern of uPAR expression on leukemic cell lines was also studied on bone marrow blast cells from leukemic patients. Only the most mature myeloid cells expressed uPAR on their surfaces. In contrast, M3 leukemic cells and other blast cells displaying lymphoid markers such as TdT (+) and/or CD2 (+) did not express intracellular or cell-surface associated uPAR, indicating an heterogeneity among these promyelocytic cells and suggesting that uPAR may be a useful marker for leukemia typing. Myeloid blast cells from some patients contained intracellular pools of uPAR but displayed no receptor on the cell surface, suggesting that translocation may be a mechanism regulating uPAR expression in these cells. The comparison of uPAR expression between these cell lines and peripheral blood cells and it correlation with plasminogen receptors, tPA receptors and LRP expression offers new insights regarding potential mechanisms for regulation of uPA-uPAR-mediated pericellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972026

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.

Authors:  Anne M Brooks; Mary Ellen Bates; Rose F Vrtis; Nizar N Jarjour; Paul J Bertics; Julie B Sedgwick
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-25       Impact factor: 6.914

2.  Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia.

Authors:  Hong Guo; Lan-Xia Zhou; Haizhen Ma; Bei Liu; Juan Cheng; Yun-Yun Ma; Li Zhao
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

3.  LDL receptor-related protein-1 regulates NFκB and microRNA-155 in macrophages to control the inflammatory response.

Authors:  Elisabetta Mantuano; Coralie Brifault; Michael S Lam; Pardis Azmoon; Andrew S Gilder; Steven L Gonias
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

4.  Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.

Authors:  P E Dekkers; T ten Hove; A A te Velde; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.

Authors:  Aaron M LeBeau; Sai Duriseti; Stephanie T Murphy; Francois Pepin; Byron Hann; Joe W Gray; Henry F VanBrocklin; Charles S Craik
Journal:  Cancer Res       Date:  2013-02-11       Impact factor: 12.701

6.  Profiling the Atlantic Salmon IgM+ B Cell Surface Proteome: Novel Information on Teleost Fish B Cell Protein Repertoire and Identification of Potential B Cell Markers.

Authors:  Ma Michelle D Peñaranda; Ingvill Jensen; Linn G Tollersrud; Jack-Ansgar Bruun; Jorunn B Jørgensen
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

7.  Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF).

Authors:  Amira Bekdash; Manal Darwish; Zahra Timsah; Elias Kassab; Hadi Ghanem; Vicky Najjar; Marwan Ghosn; Selim Nasser; Hiba El-Hajj; Ali Bazerbachi; Shihui Liu; Stephen H Leppla; Arthur E Frankel; Ralph J Abi-Habib
Journal:  Transl Oncol       Date:  2015-10       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.